Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor
- PMID: 38405
- DOI: 10.1038/281114a0
Fundamental difference between the molecular interactions of agonists and antagonists with the beta-adrenergic receptor
Abstract
Antagonist binding to the beta-adrenergic receptor is largely entropy driven, with only a small enthalpy component. The binding of agonists, on the other hand, is associated with a large decrease in enthalpy which permits a highly unfavourable decrease in entropy. The thermodynamic differences between the binding of agonists and antagonists may provide new insights into the molecular basis for hormone stimulation of adenylate cyclase activity.
Similar articles
-
Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase.Biochem Pharmacol. 1978 May 15;27(10):1445-54. doi: 10.1016/0006-2952(78)90100-4. Biochem Pharmacol. 1978. PMID: 29638 No abstract available.
-
Structure-binding-activity analysis of beta-adrenergic amines--II. Binding to the beta receptor and inhibition of adenylate cyclase.Biochem Pharmacol. 1978 May 15;27(10):1455-61. doi: 10.1016/0006-2952(78)90101-6. Biochem Pharmacol. 1978. PMID: 29639 No abstract available.
-
Interactions of agonists and antagonists with beta-adrenergic receptors.Adv Cyclic Nucleotide Res. 1981;14:51-67. Adv Cyclic Nucleotide Res. 1981. PMID: 6116391
-
On the fundamental difference in the thermodynamics of agonist and antagonist interactions with beta-adrenergic receptors and the mechanism of entropy-driven binding.Biochem Pharmacol. 1990 Aug 15;40(4):663-9. doi: 10.1016/0006-2952(90)90299-z. Biochem Pharmacol. 1990. PMID: 1974762 Review. No abstract available.
-
[Beta-adrenergic receptor characteristics in hypertension and spontaneous hypertension in rats].Kardiologiia. 1982 Mar;22(3):120-5. Kardiologiia. 1982. PMID: 6122750 Review. Russian. No abstract available.
Cited by
-
Distinct platelet thromboxane A2/prostaglandin H2 receptor subtypes. A radioligand binding study of human platelets.J Clin Invest. 1989 Dec;84(6):1883-91. doi: 10.1172/JCI114375. J Clin Invest. 1989. PMID: 2531760 Free PMC article.
-
Properties of beta-adrenoceptor sites in metabolizing and nonmetabolizing rat reticulocytes and in resealed reticulocyte ghosts.Naunyn Schmiedebergs Arch Pharmacol. 1981;317(4):286-93. doi: 10.1007/BF00501308. Naunyn Schmiedebergs Arch Pharmacol. 1981. PMID: 6119626 No abstract available.
-
Trapping of the beta-adrenergic receptor in the hormone-induced state.Proc Natl Acad Sci U S A. 1983 Nov;80(21):6441-5. doi: 10.1073/pnas.80.21.6441. Proc Natl Acad Sci U S A. 1983. PMID: 6314327 Free PMC article.
-
Kinetics and thermodynamics of activation of pretreatment with guanosine 5'-[beta, gamma-imido]triphosphate of smooth-muscle adenylate cyclase.Biochem J. 1982 Aug 1;205(2):249-55. doi: 10.1042/bj2050249. Biochem J. 1982. PMID: 7138499 Free PMC article.
-
Thermodynamics and docking of agonists to the β(2)-adrenoceptor determined using [(3)H](R,R')-4-methoxyfenoterol as the marker ligand.Mol Pharmacol. 2012 Jun;81(6):846-54. doi: 10.1124/mol.111.077347. Epub 2012 Mar 20. Mol Pharmacol. 2012. PMID: 22434858 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources